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Objective: To investigate whether there was parity
between treatment fields localized by radiographers and
clinicians, by comparing geographical variations and hence
determining the feasibility of a radiographer-led service.
Methods: 23 patients with metastatic spinal cord com-
pression (MSCC) were prospectively sampled. Four
radiographers not involved in the original planning
performed localization on each patient. The 92 local-
izations that they determined were compared with the
clinician-approved fields. Agreement was defined as
#0.5cm between field length, width and three isocentre
co-ordinates. To be feasible, agreement was required in
a minimum of 97% of the cases. The potential time saved
with a radiographer-led approach was also recorded.
Results: Agreement between clinicians and radiographers
was 97.8%. For all field parameters, the average differences
were,0.3cm andwere significantly different from the 0.5-cm
median (p,0.0001) that would establish no agreement using
Wilcoxon signed-rank test. The average (range) delay await-
ing clinician approval was 54min (4–141min).
Conclusion: Strong agreement between radiographer and
clinician localizations was established. It was also high-
lighted that time could be saved in the patient’s pathway
by removing the need to wait for clinician approval. We
believe this supports a radiographer-led service.
Advances in knowledge: This article is novel, as it is the
first known comparison between clinicians and radiogra-
phers in the localization of MSCC radiotherapy. These
data show the feasibility of introducing radiographer-led
practice and a methodology that could be potentially
transferred to investigate the localization parity for other
treatment sites.
INTRODUCTION
Metastatic spinal cord compression (MSCC) is a neuro-
logical complication of advanced malignancy1 second only
to brain metastasis in frequency. It is spinal cord and/or
cauda equina compression of the thecal sac by direct
pressure, instability by metastatic spread, induction of
vertebral collapse or direct extension of malignancy into
the epidural space.2 Once a diagnosis of MSCC has been
established, it is an emergency within oncology that
necessitates rapid onset of treatment within 24 h.2
Incidence
Not all malignancies have the same pre-disposition to cause
MSCC. Of the patients who experience MSCC, 15–20% of
MSCC is caused by lung, breast and prostate cancer;3 up to
5–10% from renal cell carcinoma, multiple myeloma and non-
Hodgkin’s lymphoma; and the remainder attributed to sar-
coma, colorectal cancer and tumours of an unknown primary.4
Therefore, the frequency of MSCC will depend on the
population of patients and their relative tumour histology.
Such that, the number of cord compressions seen is a func-
tion of the number of patients with a tumour type and the
tendency of that tumour type to metastasize to the spine.
The lack of a coding system prevents any accurate de-
termination of true spinal cord compression incidence within
the UK.2 However, with tumours most likely to cause MSCC
(prostate, breast and lung) accounting collectively for 41% of
all cancer cases,5 it is apparent that MSCC affects a relatively
large number of patients each year. Intelligent estimates put the
incidence at 4000 cases in England and Wales each year.6
Management
The management of MSCC is multimodal with steroids, surgery
and radiotherapy being utilized.7 It is often the case that one
single treatment is not used and the treatment options are ad-
juvant, with radiotherapy playing a vital role.3
Despite superiority in effectiveness of using surgery, not all
patients with MSCC are medically suitable for surgery, and ra-
diotherapy remains the primary treatment for this patient
group.8 The beneﬁts of radiotherapy for MSCC have been
demonstrated when 71% of patients investigated who received
radiotherapy for MSCC experienced pain relief, with 81% of
patients maintaining ambulatory status.9 Similarly, all patients,
who were ambulatory prior to radiotherapy (n5 93), main-
tained this status up to 20 months post treatment.3 The general
consensus is that radiotherapy is a vital and widely utilized
treatment modality for patients with established MSCC.10
The conventional technique used to treat MSCC is very similar
across Europe.11 A single posterior beam centred at the level of
compression, at depth to the anterior spinal cord is used. The ﬁeld
width is typically 8–10 cm to the distal aspect of the transverse
processes.7,12 It is also well established that one uninvolved verte-
brae above and below the level of compression should be irradiated
owing to a high rate of recurrence in these vertebrae,13 with the
superior and inferior borders placed at the intervertebral spaces.
Advances in radiotherapy have led to a number of novel treat-
ment modalities being observed such as intensity-modulated
radiotherapy and stereotactic radiosurgery;14–16 however, spe-
ciﬁc work2 relating to the radiotherapy process, improving the
efﬁciency of conventional practice and the patient pathway has
not been found, although it has been recommended.
Radiotherapy pathway
Any delay in the pathway can have a signiﬁcant impact on the
timing of treatment and thus a detrimental effect on patient
experience.17 One way to improve MSCC radiotherapy would be
to optimize the associated pathway, to maximize efﬁciency to meet
the demands set by National Institute for Health and Care Ex-
cellence (NICE)2 and to ensure that treatment delivery is on the
same day as the planning scan. In addition, patients with MSCC
can often be in pain and discomfort,18 and waiting for prolonged
periods may make the patient more uncomfortable.
Current practice in our radiotherapy department demonstrates
that, once the patient is referred, every stage in the pathway is
radiographer led, other than the approval of the treatment ﬁeld
(Figure 1), and this stage is where the most signiﬁcant and regular
delays occur.
There are a number of potential justiﬁcations for this delay.
Firstly, there is often a conﬂict in demand for clinician time, for
example, attending clinics, ward rounds, Multidisciplinary Team
(MDT) meetings and organ contouring, that they are not avail-
able to attend localization. In addition, the emergency ad hoc
nature of patients with MSCC means that they are not always
booked in line with that particular clinical team’s availability.
With a standardized technique and protocols to follow, there is
little subjectivity attributed to localizing MSCC. For the majority
of localizations, it is the researcher’s experience that the initial ﬁeld
localized by a radiographer is not changed by a clinician; hence,
the delay caused by waiting for approval may be unnecessary.
The large workload of clinical oncologists has been acknowl-
edged in the National Radiotherapy Advisory Group report19
which drew attention to their expanding patient base and the
fact that many clinical oncologists are “hard pressed”. Renego-
tiating roles within radiotherapy and transferring some of their
tasks to radiographers, namely localizing MSCC radiotherapy
would help to reduce this workload.
If the need for clinician approval is removed and radiographers are
given authorization to approve these treatments, the delays that
can occur could be eliminated. This would improve the service
through streamlining the pathway and enhance patient experience
owing to a reduction in waiting time from planning to treatment.20
Although there are no published studies comparing clinician and
radiographer localization for MSCC radiotherapy, there is evi-
dence to show a considerable degree of parity in treatment ver-
iﬁcation21 and breast simulation22 (97% and 97.3%, respectively).
We have therefore investigated whether there is parity between
clinicians and radiographers in the localization of MSCC.
Professional development
The renegotiation of National Health Service (NHS) roles is not
a novel concept,23 with changes in workforce conﬁguration and
skill mix being a growing trend for a number of years.24 Reasons
are being attributed to the need to improve organizational effec-
tiveness and pressures for better management of labour costs.25
Within radiography, the four-tier service model was introduced
by the Society and College of Radiographers (London, UK)26
with the aim of establishing consultant and advanced practice
roles. The target of this model is to make more effective use of
clinical oncologists’ time by delegating certain roles to radiog-
raphers19 in view of the expanding workload.
Figure 1. The local metastatic spinal cord compression pathway.
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The introduction of radiographer-led localization for MSCC
could help to establish progression into these advanced roles.
This is because it would achieve the characteristics required at
this level of expert clinical practice, service development and
consultancy.22 Where these roles have been introduced, they
have demonstrated the potential to make more efﬁcacious use
of clinical oncologists’ time as well as drive patient pathway
efﬁciency, reduce waiting times and offer a more patient-led
service.19
METHODS AND MATERIALS
From April 2014, every consecutive patient with MSCC re-
quiring treatment on the same day as planning CT was selected.
Patients also must have had MRI conﬁrmation of MSCC and
a completed radiotherapy referral stating the speciﬁc vertebral
levels to be treated.
Radiographers who had been trained in virtual simulation as
part of the radiotherapy department’s clinical competency
framework were included in the study. This required prior
training in localizing palliative radiotherapy ﬁelds and comple-
tion of an associated competency workbook. This involved re-
cording a log of experiences complemented by reﬂective
practice. Therefore, radiographer grade was not discriminated
against, providing the radiographer was trained and completed
the workbook, they were included.
In addition, the radiographers who took part in the original
localization and checking of the ﬁeld with the clinician were
excluded for that particular data set. This was to remove recall
bias and the associated threat to data reliability this yields.27
Data collection
Once referred for treatment and consented, the patient had
planning CT as per normal clinical procedure, that is, positioned
supine, arms by their sides with a knee pad. Once completed, the
CT data set was sent to the treatment planning system. An initial
ﬁeld to treat compression was localized by a radiographer under
normal departmental procedure. After initial localization, a cli-
nician was called to review the ﬁeld, to make any requisite
changes and to approve the treatment.
The time taken for a clinician to attend, from the moment they
were contacted to the time when the treatment was approved,
was recorded.
Once completed, the ﬁeld size was recorded by the researcher to
determine the differences in irradiated volume, and the isocentre
co-ordinates were recorded to provide geographical differences
including the treatment depth chosen.
The planning referral and CT scan were then anonymized, and
four radiographers not involved in the original localization in-
dependently localized a treatment ﬁeld.
Once the four independent localizations had been performed,
the radiographer data (DATArad) was compared with the clini-
cian data from the original approved treatment ﬁeld (DATAclin).
This was performed by the researcher.
Rate of agreement
Based on previous studies investigating parity,21,22 the primary
end point in this study was 97% agreement between radiographers
and clinicians. This rate of agreement would establish parity be-
tween them indicating that a radiographer-led service is feasible.
To reinforce the need for 97% agreement, it has also been
suggested that 87.5% agreement between radiographers and
clinicians is not sufﬁciently high to support a radiographer-led
system.28 Therefore, a higher rate of agreement is needed, and
thus, 97% could be argued as showing sufﬁcient parity.
Classification of agreement
For the purpose of this study, agreement was classiﬁed as
#0.5 cm between ﬁeld length, width and three isocentre co-
ordinates. If any one of the ﬁve parameters was greater than this
tolerance, the localization was deemed as not in agreement.
The justiﬁcation for this was 0.5 cm is within the imaging tol-
erance that MSCC would be treated within the researchers’ ra-
diotherapy department. Also, as one uninvolved vertebrae above
and below the actual compression is treated (Figure 2a), and the
lateral margins are .1 cm (Figure 2b) when the edge of trans-
verse processes are used, a 0.5 cm displacement at localization
would not illicit a geographical miss of the compression at
treatment delivery.
Sample size
Assuming that the true rate of agreement is 97%, the sample size
for this study in order to prove the rate is greater than a minimum
of 90% was 92 localizations when a one-sided alpha of 0.05 was
used in order to obtain an associated statistical power of 85%
which is above the benchmark of 80% power for results to be
valid and reliable.29 This was calculated using SPSS® (IBM Cor-
poration, Armonk, NY; formerly SPSS Inc. Chicago, IL). There-
fore, 23 patients would be needed as 4 different radiographers
would perform a localization for each patient, to be compared
with the clinician-approved ﬁeld used to treat the compression.
Statistical considerations
To analyse the data, descriptive statistics was used to quantify
and illustrate the differences in ﬁeld parameters between radi-
ographers and clinicians. In addition to highlighting the level of
parity between the two professional groups, this also enabled
evaluation of interradiographer variability.
Once the data had been collected, it was evident that the con-
ditions of normality were not met. The non-parametric data were
therefore tested using Wilcoxon signed-rank test in order to ob-
tain the respective p-values for each of the ﬁve ﬁeld parameters.
Ethical approval
This study did not involve any change to clinical care of the
patient or any identiﬁable patient data. It therefore did not re-
quire ethical review by a NHS or social care research ethics
committee, or management permission through the NHS re-
search and development ofﬁce. Ethical approval was sought
through the trusts’ clinical audit committee to ensure compli-
ance with the trusts’ ethical policy.
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RESULTS
In 90 of the 92 localizations, parity with the clinicians was
established in all of the ﬁve parameters measured resulting in an
overall rate of agreement of 97.8%. The average differences were
,3mm in all parameters and signiﬁcantly different from 0.5 cm
(Wilcoxon signed-rank test) (Table 1).
The results also showed a trend of the radiographers to localize
a smaller ﬁeld width (49% smaller, 34% larger and 17% no
change) which can be observed in Figure 3 and a smaller ﬁeld
length (48% smaller, 33% larger and 19% no change) compared
with the approved clinician ﬁeld (Figure 4).
The average delay in waiting for a clinician to approve the
original ﬁeld was 54min (standard error5 0.61), and the range
of time delay was 4–145min (Figure 5).
DISCUSSION
Rate of agreement
We have demonstrated that radiographer localization of MSCC
agreed with clinicians 97.8% of the time, hence rendering the
average delay of nearly an hour unnecessary.
The results here are comparable with those previous similar
studies21,22 where parity was found. In both cases, clinical
implementation of the radiographer-led service took place with
satisfaction that practice was safe and of no detriment to patients.
Furthermore, the rate of agreement of the results in this study is
greater than the recommended threshold of 87.5%28 to imple-
ment a radiographer-led service. Moreover, this study has shown
that in relation to localizing the treatment ﬁelds for MSCC,
a radiographer-led service is a safe and feasible option.
Geographical variations
Firstly, the very high rate of agreement illustrates the small geo-
graphic variation in the ﬁeld produced by the two groups. This is
further reinforced by the fact that in 100% of the localizations, the
isocentre co-ordinates agreed with those of the clinician.
This underpins the very robust nature of the treatment protocol
used to treat MSCC and the lack of subjectivity involved. The
treatment ﬁelds are localized based on anatomical landmarks,
with little justiﬁcation to deviate from these. Therefore, radi-
ographers localize extremely similar ﬁelds as a clinician in order
to treat the same MSCC.
In the case of this study, the radiographers were given an
identical albeit anonymized copy of the original treatment re-
ferral describing the vertebral levels to be irradiated. However,
this meant that all clinical information on the electronic patient
record system along with associated diagnostic imaging, notably
MRI which was available to the clinician when approving the lo-
calization and was not accessible to the radiographers. In light of
this limitation and the fact that they still achieved 97.8% agreement
again highlights the minimal difference between the two groups.
In the two cases whereby radiographer localization did not agree
with clinician localization, both were due to the ﬁeld width
exceeding the 0.5-cm tolerance. Although this was only by 0.1
and 0.5 cm, it is still important to explore possible causes. In
both of these cases, the patient had a soft-tissue deposit. This has
shown that the radiographers have placed a margin on this
disease albeit slightly larger than that by the clinician.
In view of the fact that MRI was not available, it could be argued
that this may be a case of being cautious to ensure that the
disease would be adequately treated. The superior image quality
of MRI that would have been available to the clinician meant
that they could have made a more accurate assessment as to the
requisite ﬁeld width needed to treat the compression. However,
in these two cases, the disease had a greater margin on it;
therefore, the inference can be made that without similar im-
aging, the radiographer-ensured disease was adequately covered
to minimize the risk of geographical miss.
Finally, when discussing the geometric and geographic results of
this study, a pattern emerged that illustrated a tendency of the
radiographers to localize slightly smaller ﬁelds than the clinician.
Reasons for this could be that, again, radiographers as pro-
fessionals are process and protocol driven, with a tendency not
to deviate from protocol or work outside of their delegated role.
Therefore, they could be less likely than clinicians to increase
ﬁeld sizes beyond the anatomical landmarks required.
Figure 2. (a) Sagittal view of field placement. (b) Axial view of field placement.
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Radiographers also have a greater knowledge and awareness of
image veriﬁcation performed at treatment, its efﬁcacy and the
implications this has on improved treatment accuracy. Moreover,
this could lead to radiographers having greater conﬁdence on
standard margins used to treat MSCC compared with clinicians and
therefore tend not to increase the ﬁeld borders beyond this standard.
Time delay
An average delay of 54-min waiting has highlighted that clinical
oncologists are not always readily available to attend straight
away. These data have not been recorded to expose non-
punctilious behaviour of the clinicians involved but to show that
attending virtual simulation at any time is not conducive in line
with their expanding workload and clinical commitment. As
a result of this, there is an associated delay awaiting this 24-hour
radiotherapy pathway that has the potential to be removed.
Service improvement
The outcomes of this study have shown an optimal area,
whereby the clinician’s workload could be alleviated whilst
improving patient service. The role of localizing treatment of
MSCC could be delegated to radiographers, given the very
strong level of agreement established here.
A radiographer-led service for patients with MSCC would yield
a more efﬁcient and streamlined pathway through the removal
of this delay. This is in line with high standards of patient care
owing to the fact that there is signiﬁcant agreement between
clinicians and radiographers in the execution of treatment lo-
calization. Reducing waiting times would also have a positive
impact on patients.20
It is important to also highlight that the delay caused at virtual
simulation is not the true reﬂection of the actual delay experi-
enced. This delay has an accumulative effect, and there is the
potential for the delay to be more signiﬁcant in latter stages of
the patient pathway.
Cost saving
From an operational perspective, the elimination of delay as-
sociated with the clinician-led service would also reduce the
potential of requiring radiographers to work out of hours. If the
localization is not performed in a timely manner, the delivery of
treatment may be out of hours. This will clearly have implications
to the cost of the service as overtime caused by radiographers
working late would be reduced.
There are potential further cost-saving beneﬁts to a radiogra-
pher-led service in view of concepts such as activity-based
costing. Systems such as these may show that in fact it is cost
beneﬁcial to have radiographers perform a task previously per-
formed by clinicians. Therefore, a radiographer-led service
would show better management of labour costs and organiza-
tional effectiveness.25 Again, the potential beneﬁts based on this
Figure 3. Difference in field width between clinician and radiographer.
Table 1. Average differences between radiographers and clinicians
Field
parameter
Average difference
(standard
error) (cm)
Difference from
0.5 cm, p-value
x co-ordinate 0.17 (0.01) ,0.0001
y co-ordinate 0.16 (0.02) ,0.0001
z co-ordinate 0.09 (0.01) ,0.0001
Field length 0.22 (0.03) ,0.0001
Field width 0.27 (0.03) ,0.0001
Full paper: Radiographer vs clinician localization for MSCC radiotherapy BJR
5 of 7 birpublications.org/bjr Br J Radiol;88:20150586
study are shown, suggesting that a radiographer-led service is
a viable option to improve the service, and although it would
need support from a strategic level in order for it to be imple-
mented effectively, it would have the potential to improve the
pathway for patients with MSCC considerably.
Professional development
The results of the study have clearly shown that radiographers
are capable of localizing MSCC radiotherapy accurately and
safely without the need of clinician approval. The outcome of
97.8% agreement supports the notion that this role could be
delegated to radiographers; in turn improving the proﬁle of the
profession with the introduction of advanced practice roles,
given the associated characteristics, expert clinical practice,
service development and consultancy.22
Moreover, it has been shown that a radiographer-led service could
be implemented that would ultimately make this cancer service
more responsive to the needs of the patient, in line with historic
government targets that staff need to renegotiate their roles.23
Strengths and limitations of the study
As previously highlighted, there was assumed independence
between the four radiographers involved in the localization of
a patient. Ideally, 92 patients would have been recruited to meet
the sample of 92 localizations; however, it was not possible
owing to the time limits set and presented an obvious limitation
to the study.
In addition, the time delay itself had been obtained but the
reason for the delay was not. In retrospect, it may have been
Figure 5. Approval time delay.
Figure 4. Difference in field length between clinician and radiographer.
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beneﬁcial to the study to have ascertained a reason for the
delay. This would have aided the discussions of the results and
enabled some inferences to be drawn as to the source of the
delay from a clinician’s perspective. This poses a potential for
further study.
CONCLUSION AND RECOMMENDATIONS
Within the 0.5-cm tolerance set within this study, there is a robust
agreement between clinicians and radiographers in localizations of
MSCC radiotherapy. As a result, evidence is presented that supports
the implementation of a radiographer-led service for this patient
group in order to streamline the patient pathway and make the
service more efﬁcient in line with high standards of patient care.
It is recommended that the radiographer-led service be clinically
implemented in the ﬁrst instance as a trial basis. A sample of the
ﬁrst patients could then be retrospectively evaluated to see whether
they were changed at audit after localization had been approved by
trained radiographers. Assessment of the frequency that they are
changed and the associated magnitude of any changes made
should be performed in order to evaluate the accuracy and safety
of this service. The time saved could also be evaluated in order to
assess whether or not the pathway has in fact been streamlined.
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